Literature DB >> 15174762

Combination of fascia transplantation and fat injection into the vocal fold for sulcus vocalis: long-term results.

Ming-Wang Hsiung1, Bor-Hwang Kang, Lu Pai, Wan-Fu Su, Yaoh-Hsiang Lin.   

Abstract

Fat injection and fascia transplantation alone have been used to treat patients with sulcus vocalis. No information is available on the effectiveness of these two procedures used in concert to treat sulcus vocalis. The objectives of this study were to conduct the two procedures together and report the long-term results. This article assesses, retrospectively, the effectiveness of the combination treatment of fascia transplantation and fat injection (FTFI) in patients with sulcus vocalis (n = 22). Perceptual acoustic, phonatory function, and videolaryngostroboscopic data were evaluated before and after FTFI treatment in 18 patients. The mean follow-up time was 16.6 months. Sixteen patients had excellent results, 3 reported improvement, and 3 indicated no change. Phonatory function improved significantly in terms of phonation time, grade, roughness (p < .05), and breathiness (p < .001). The videolaryngostroboscopic rating showed significant improvement in vocal fold vibration amplitude and excursion of the mucosal wave (p < .05). Type 3 sulcus responded better to this treatment than did type 2 (sulcus vergeture). No postoperative complications were noted. The FTFI technique consists of an autogenous implant and delivers positive results. It may be considered as an option for patients with sulcus vocalis. It has been demonstrated to achieve excellent results in a majority of patients and to deliver a better prognosis than fat injection alone. Although resorption of fat and fascia is associated with FTFI, the FTFI procedure may be repeated multiple times.

Entities:  

Mesh:

Year:  2004        PMID: 15174762     DOI: 10.1177/000348940411300504

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  8 in total

1.  Sulcus vocalis: excision, primary suture and medialization laryngoplasty: personal experience with 44 cases.

Authors:  Taner Yılmaz
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-06-06       Impact factor: 2.503

2.  Quantitative study of vibrational symmetry of injured vocal folds via digital kymography in excised canine larynges.

Authors:  Christopher R Krausert; Di Ying; Yu Zhang; Jack J Jiang
Journal:  J Speech Lang Hear Res       Date:  2010-12-20       Impact factor: 2.297

Review 3.  Sulcus vocalis: a review.

Authors:  Antoine Giovanni; Cécile Chanteret; Aude Lagier
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-01-13       Impact factor: 2.503

4.  Local vascularized flaps for augmentation of Reinke's space.

Authors:  Seth H Dailey; McLean Gunderson; Roger Chan; Jose Torrealba; Miwako Kimura; Nathan V Welham
Journal:  Laryngoscope       Date:  2011-02       Impact factor: 3.325

5.  Prospective multi-arm evaluation of surgical treatments for vocal fold scar and pathologic sulcus vocalis.

Authors:  Nathan V Welham; Seong Hee Choi; Seth H Dailey; Charles N Ford; Jack J Jiang; Diane M Bless
Journal:  Laryngoscope       Date:  2011-05-06       Impact factor: 3.325

6.  Nonlinear dynamic-based analysis of severe dysphonia in patients with vocal fold scar and sulcus vocalis.

Authors:  Seong Hee Choi; Yu Zhang; Jack J Jiang; Diane M Bless; Nathan V Welham
Journal:  J Voice       Date:  2012-04-18       Impact factor: 2.009

7.  Practice variations in voice treatment selection following vocal fold mucosal resection.

Authors:  Jaime E Moore; Paul J Rathouz; Jeffrey A Havlena; Qianqian Zhao; Seth H Dailey; Maureen A Smith; Caprice C Greenberg; Nathan V Welham
Journal:  Laryngoscope       Date:  2016-03-12       Impact factor: 3.325

8.  Bilateral vocal fold injection with autologous fat in patients with vocal fold atrophy with or without sulcus.

Authors:  Emke M J M van den Broek; Bas J Heijnen; Martine Hendriksma; Vivienne A H van de Kamp-Lam; Antonius P M Langeveld; Peter Paul G van Benthem; Elisabeth V Sjögren
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-05-27       Impact factor: 2.503

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.